AU2016273068A1 - Pharmaceutical compositions of dimethyl fumarate - Google Patents

Pharmaceutical compositions of dimethyl fumarate Download PDF

Info

Publication number
AU2016273068A1
AU2016273068A1 AU2016273068A AU2016273068A AU2016273068A1 AU 2016273068 A1 AU2016273068 A1 AU 2016273068A1 AU 2016273068 A AU2016273068 A AU 2016273068A AU 2016273068 A AU2016273068 A AU 2016273068A AU 2016273068 A1 AU2016273068 A1 AU 2016273068A1
Authority
AU
Australia
Prior art keywords
dimethyl fumarate
pharmaceutical composition
oral pharmaceutical
composition
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016273068A
Other languages
English (en)
Inventor
Vimal Kaneria
Amol Kulkarni
Shirish Kulkarni
Mukesh Sharma
Rajamannar Thennati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of AU2016273068A1 publication Critical patent/AU2016273068A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
AU2016273068A 2015-06-01 2016-06-01 Pharmaceutical compositions of dimethyl fumarate Abandoned AU2016273068A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2125/MUM/2015 2015-06-01
IN2125MU2015 2015-06-01
PCT/IN2016/050164 WO2016194004A1 (en) 2015-06-01 2016-06-01 Pharmaceutical compositions of dimethyl fumarate

Publications (1)

Publication Number Publication Date
AU2016273068A1 true AU2016273068A1 (en) 2017-12-21

Family

ID=57397432

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016273068A Abandoned AU2016273068A1 (en) 2015-06-01 2016-06-01 Pharmaceutical compositions of dimethyl fumarate

Country Status (5)

Country Link
US (2) US10085961B2 (de)
EP (1) EP3302461A4 (de)
AU (1) AU2016273068A1 (de)
CA (1) CA2987895A1 (de)
WO (1) WO2016194004A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021012441A (es) * 2019-05-31 2022-10-07 Curacle Co Ltd Tableta enterica que contiene fumarato de dimetilo.

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1153927A (en) * 1966-08-25 1969-06-04 Wilhelm Hoerrmann Medicinal Composition Suitable For Treating Diseases Of The Retina
US4959389A (en) * 1987-10-19 1990-09-25 Speiser Peter P Pharmaceutical preparation for the treatment of psoriatic arthritis
DE19853487A1 (de) * 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
DE10000577A1 (de) 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
EP1709958A1 (de) * 2002-12-05 2006-10-11 Symrise GmbH & Co. KG Nahtlose gefüllte Kapseln
AU2004269903B2 (en) * 2003-09-09 2010-09-02 Biogen International Gmbh The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
PT2801354T (pt) * 2004-10-08 2017-06-05 Forward Pharma As Composições farmacêuticas de libertação controlada compreendendo um éster de ácido fumárico
JP2009510137A (ja) 2005-10-07 2009-03-12 アディテック・ファルマ・アクチボラゲット フマル酸エステルを含む制御放出医薬組成物
EP2680007A1 (de) 2007-02-08 2014-01-01 Biogen Idec MA Inc. Nrf2-screening-Assays sowie entsprechende Verfahren und Zusammensetzungen
US20120034274A1 (en) 2009-01-09 2012-02-09 Forward Pharma A/S Pharmaceutical composition comprising one or more fumaric acid esters
UA112975C2 (uk) 2009-01-09 2016-11-25 Форвард Фарма А/С Фармацевтичний склад, що містить в матриці, яка піддається ерозії, один або більше ефірів фумарової кислоти
CA2865316A1 (en) * 2011-04-28 2012-11-01 Gino Cortopassi Agents useful for treating friedreich's ataxia and other neurodegenerative diseases
CN103649041A (zh) * 2011-06-08 2014-03-19 比奥根艾迪克Ma公司 制备高纯度和结晶的富马酸二甲酯的方法
RU2014125430A (ru) 2011-11-24 2015-12-27 Синтон Бв Контролируемое высвобождение частиц, содержащих диметилфумарат
US20130216615A1 (en) 2012-02-07 2013-08-22 David Goldman Pharmaceutical Compositions Containing Dimethyl Fumarate
US9597292B2 (en) 2012-08-22 2017-03-21 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
KR101379427B1 (ko) * 2013-02-13 2014-03-28 경북대학교병원 디메틸푸마레이트를 유효성분으로 포함하는 신섬유증의 예방 또는 치료용 조성물
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
KR20210139485A (ko) * 2013-08-26 2021-11-22 에프더블유피 아이피 에이피에스 디메틸푸마레이트를 포함하는 일일 저용량 투여용 약제학적 조성물
WO2015042294A1 (en) 2013-09-18 2015-03-26 Xenoport, Inc. Nanoparticle compositions of dimethyl fumarate
LT3079666T (lt) 2013-12-12 2021-03-25 Almirall S.A. Farmacinės kompozicijos, apimančios dimetilfumaratą
AU2015222880B2 (en) 2014-02-28 2016-11-24 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
MA40990A (fr) 2014-11-19 2017-09-26 Biogen Ma Inc Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle
MA40982A (fr) 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
EP3250198A1 (de) 2014-12-04 2017-12-06 Biogen MA Inc. Behandlungsschema für multiple sklerose mit dimethylfumarat
WO2016113754A2 (en) 2015-01-14 2016-07-21 Leiutis Pharmaceuticals Pvt, Ltd. Novel oral dosage forms of dimethyl fumarate
MX2018005345A (es) * 2015-10-28 2018-08-14 Sun Pharmaceutical Ind Ltd Composiciones farmaceuticas de dimetil fumarato.

Also Published As

Publication number Publication date
EP3302461A1 (de) 2018-04-11
CA2987895A1 (en) 2016-12-08
US20160346393A1 (en) 2016-12-01
US20180369183A1 (en) 2018-12-27
WO2016194004A1 (en) 2016-12-08
US10085961B2 (en) 2018-10-02
EP3302461A4 (de) 2019-02-13

Similar Documents

Publication Publication Date Title
US11173123B2 (en) Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
AU2019268049B2 (en) Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose
US20120034274A1 (en) Pharmaceutical composition comprising one or more fumaric acid esters
US20130280324A1 (en) Sustained release pharmaceutical compositions comprising pregabalin
WO2017208136A1 (en) Pharmaceutical composition of dapagliflozin co-crystal
CN113645962A (zh) 含有富马酸二甲酯的肠溶片剂
WO2017093444A1 (en) Compositions for oral administration in the treatment of inflammatory bowel disease
US9132092B1 (en) Pharmaceutical composition of doxycycline
US10085961B2 (en) Pharmaceutical compositions of dimethyl fumarate
US8945616B2 (en) Controlled release budesonide minitablets
AU2016344673A1 (en) Pharmaceutical compositions of dimethyl fumarate
WO2020112060A1 (en) A composition comprising dimethyl fumarate
JP7195354B2 (ja) 浸食マトリックス中に１またはそれ以上のフマル酸エステルを含む医薬製剤

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period